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Abstract 
Aim of this study was the set-up of gelatin and carbon nanotubes (CNTs) scaffolds for cardiac 
tissue engineering applications. Gelatin-based scaffolds and SingleWalled CNTs (0.3% and 0.9%), 
cross-linked with genipin 0.2%, were prepared. H9c2 cell line was cultured for 10 days in culture 
medium, supplemented with 10% of FBS (C10%). Myoblast differentiation was induced by FBS 
reduction to 1% (C1%), while cardiac phenotype by stimulation with 50 nM all trans-retinoic acid 
(CRA). Cell viability, citotoxicity, phenotype differentiation, immunohistochemical assay and Real-
Time PCR analysis were performed. Immunohystochemistry showed elongated myotubes in C1%, 
(skeletal phenotype) and round and multinucleated cells in CRA (cardiac phenotype), as confirmed 
by a significantly increased expression of Natriuretic Peptides (NP)-system in CRA with respect to 
C10% and C1% as well as of ET-A and ET-B receptors in parallel with a decreased ET-1. In SWCNTs 
cell viability was similar both at 0.3% and 0.9%; NP and ET-systems expression decreased in 
SWCNT0.3% and SWCNT0.9% with respect to C10%, as well as CX-43 mRNA (p<0.01), mainly due to 
a lacking of complete differentiation in cardiac phenotype during these few days. Although further 
analyses on novel biomaterials are necessary, these results represent a useful starting point to 
develop new scaffold-based biomaterials. 
 
Keywords: tissue engineering, scaffolds, SingleWalled carbon nanotubes, trans-retinoic acid, 
natriuretic peptides, endothelin system 
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INTRODUCTION 
Cardiovascular disease (CVD) remains the leading cause of death among European countries and in 
Italy it represents the 44% of all death among population.
1 
The clinical course of cardiovascular 
diseases, mainly heart failure (HF), is unpredictable and, often, patients with end-stage HF 
refractory to medical treatment required advanced specialized treatments, fluid removal procedures, 
experimental surgery or durable left ventricular assist device (LVAD) until the end-of-life.
2
 
However, the only effective treatment is heart transplantation but due to the scarce supply of donor 
hearts, only few patients receive this procedure.
3
 To address this problem, current research has been 
directed towards cell-based therapies
4
 and cardiac tissue engineering.
5 
Cardiac tissue engineering is 
a multidisciplinary field that brings together the principles of cellular biology, material science and 
biomedical engineering for regenerative medicine development, providing force-producing heart 
muscle tissue that could be transplanted on injured hearts restoring their function.
6
 Cardiac tissue 
engineering is based on design of bioactive biomaterials, called scaffolds, usually seeded with cells 
and able to be used for in-situ cardiac repair through promoting vascularization or cell recruitment, 
survival and growth.
7 
Scaffolds are biodegradable structures with mechanical/electrical properties 
mimicking the native tissue, and can be manipulated into various shapes or sizes.
8 
However, a great 
number of injectable scaffolds developed for myocardial applications are non-conductive, lack 
nanofibrous architectures on the submicrometer scale (10-100 nm in diameter) and are mechanically 
weaker than native heart tissues
9
: for these reasons different materials have been identified to 
ameliorate scaffolds’ properties. Among them, Carbon Nanotubes (CNTs) are certainly numbered 
as the most interesting ones being hypothetically the ideal material for a successful biomaterial in 
cardiac applications. The CNTs dimensions range from 1 to 100 nm, showing high mechanical and 
electrical properties, low weight and either chemical and thermal stability.
10
 For cardiac tissue 
engineering, both single- and multi-walled CNT (SWCNTs and MWCNTs, respectively) are used to 
create scaffolds with a specific elastic modulus and electrical nature making them suitable as 
optimal interface with excitable cells, such as heart myocytes. The cardiomyocytes, interacting with 
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CNT scaffolds, are able to modify their viability, proliferation, growth, maturation and 
electrophysiological properties.
11,12
 
In the light of these observations, aim of this study was to set up gelatin-based CNT scaffolds for 
cardiac tissue engineering applications and to evaluate their biological properties in inducing 
phenotypic changes in an in-vitro experimental model of H9c2 cell line.  
MATERIALS AND METHODS 
Conductive scaffolds preparation 
Single walled nanotubes (SWCNTs) were sterilized under UV for 15 minutes and then used to 
prepare a solution in distilled water with a concentration of 0.75% w/v. To increase dispersion of 
unsoluble nanotubes, 100 µL of Tween 20 were added. The mixture was sonicated (Vibra Cell 
VC130, Sonics & Materials Inc., Newton, USA) for 2 hours (5 minutes break every 30 minutes of 
sonication, 2W power). For scaffold fabrication, a solution of porcine gelatin 5% w/v (Sigma 
Aldrich, St. Louis, MO, U.S.A) in distilled water was prepared. SWCNTs were added to gelatin 
solution to obtain samples at different concentration: 0.3%, 0.5%, 0.7%, 0.9%, 1.3% w/w per 
gelatin weight. Then, the cross-linker genipin (GP) 0.2% w/v was added to the gelatin-SWCNT 
mixture and each dispersion was then homogenized by sonication. At the end, 500 µL of gelatin-
SWCNT were pipetted in a 12-multiwell plate and incubated at 37°C for 48h. To complete the 
sterilization process, ethanol 70% was added in each well and the plate was placed at 4°C for 24h, 
followed by several washes with PBS solution. Before cell seeding, the multiwell plate containing 
the scaffolds was exposed to UV lamp for 30 minutes. 
Mechanical characterization 
For mechanical and impedance tests, gelatin-SWCNT scaffolds were prepared with the previous 
protocol but solutions were casted in Petri dishes for 48 hours at room temperature. They were cut 
in a strip shape, hydrated for 8 minutes, to reach the swelling equilibrium and then they were 
subjected to tensile tests till break, with a deformation rate of 1%/min, using a uniaxial testing 
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machine Zwick-Roell Z005 (Zwick GmbH & Co, Germany). The tests were performed in triplicate. 
The elastic modulus was calculated from the slope of the first linear part of the stress-strain curve. 
Impedance tests 
Impedance was measured using 2MHz precision LCR meter Agilent E4890A (Agilent 
Technologies, Santa Clara CA, USA). Copper tape strips were attached to the end of each samples 
to plug in clamps of impedance analyzer. A total of 133 different frequencies were measured 
between 1 kHz and 2 Mhz. The tests were performed in triplicate. 
Cell culture  
H9c2 rat cardiomyoblast cell line (ATCC-CRL-2522, Teddington, UK) were cultured in High 
Glucose DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Foetal 
Bovine Serum), 2 mM L-Glutamine, 100 µU/mL Penicillin, 10-1µU/mL Streptomycin and 2.5x10-
1µU/mL Amphotericin B. All these products were purchased at Sigma-Aldrich (St. Louis, MO, 
U.S.A.). Cells were cultured in 75 cm
2
 flasks at 37°C in a humidified atmosphere of 5% CO2 
changing medium every 2/3 days and amplified until reached confluence.  
Cytotoxicity  
Each sample of gelatin-SWCNT scaffold was extracted at 37 °C for 24 h in 3 mL of DMEM 
complete medium, described above. Complete medium supplem nted with 5% DMSO was used as 
positive control. Cells cultured in standard medium were used as negative control. 
Cells were seeded at confluence in 96-well plate and, once adhered, medium was changed with 200 
µl of the extracted one (at least 6 wells). After exposure to the extract for 72 h at 37 °C, changes of 
cellular morphology were evaluated with AX70 light-reverted microscope (Olympus, Milan, Italy) 
and cell viability was tested by using Promega CellTiter Blue
®
 (Madison, WI, USA). In each well 
100 µl of fresh new medium were added together with 10 µl of reagent. After 150 min, the Relative 
Fluorescent Unit (RFU) values were evaluated with spectrophotometer plate reader (579ex/584em) 
(BMG LabTech, Fluostar Omega, Ortemberg, Germany). Samples with a viability value of at least 
70% were selected for the cell culture growth profile. 
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Cell growth 
Cells at confluence were washed with 5 ml of PBS, detached by 3 ml of Trypsin [0.25% (w/v)] and 
placed in contact with 12 ml of fresh complete medium to deactivate enzyme action. H9c2 were 
counted with haemocytometer and seeded on the scaffolds at a cell density of 40% (56000 
cell/cm
2
). At well-defined times (1, 3, 7 days) medium cell culture wash changed. The experiment 
had a duration of 10 days. 
Differentiation protocol 
In order to evaluate the potential cardiac or myogenic differentiation process induced by SWCNT-
based scaffolds, a differentiation protocol was applied. After cell seeding, control samples were 
divided as follows: 
• negative control (C10%): cells with DMEM complete medium supplemented with 10% FBS; 
• positive control 1 (C1%): cells with DMEM medium supplemented with 1% FBS, useful to 
evaluate potential myogenic differentiation; 
• positive control 2 (CRA): cells with DMEM medium supplemented with 1% FBS and 50 nM 
retinoic acid, useful to evaluate potential cardiac differentiation. 
At well-defined times (1, 3, 7 days) culture medium was changed. The experiment had a duration of 
10 days. 
Immunohistochemical analysis 
Paraformaldehyde-fixed samples were treated for evaluation of Myogenin (for myogenic 
differentiation) and Myosin regulatory light chain 2 (MYL2, for cardiac differentiation). Myogenin 
was recognized by and anti-rat Myogenin (F5D) mouse primary antibody and, for analysis on 
scaffolds, a DAPI-conjugated secondary antibody (donkey anti-mouse IgG-DAPI) was used, while 
for controls, a FITC-conjugated secondary antibody (donkey anti-mouse IgG-FITC) was used. In 
the same way, MYL2 was identified by anti-rat MYL2 (C-17) goat primary antibody and, for 
analysis on scaffolds, a DAPI-conjugated secondary antibody (rabbit anti-goat IgG-DAPI) and, for 
controls, a TRITC-conjugated secondary antibody (rabbit anti-goat IgG-TRITC) were used. All the 
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primary antibodies were purchased at Santa Cruz Biotechnology (Dallas, TX, USA) while 
secondary at ThermoFisher Scientific (Waltham, MA, USA). Samples were washed three times 
with PBS for 5 min and treated with 0.1% Triton in PBS for 2 min at room temperature to 
permeabilize cell membranes. Samples were left in 5% BSA for 30 min and then treated with the 
primary antibody, 1:50 diluted in 1% BSA, for 1 h at 37°C. Then, the secondary antibody 1:100 
diluted in 1% BSA was added to the samples for 1 hat 37°C. At the end of incubation, each sample 
was washed three times with PBS for 5 min. Finally, samples were analyzed at the fluorescence 
microscope (CX40, Olympus, Milan, Italy). 
Molecular biology analysis: from RNA extraction to Real-Time PCR 
Total RNA was extracted from H9c2 cell line by acid guanidinium thiocyanate-phenol-chloroform 
(TRI Reagent Sigma Aldrich) following RNeasy Mini kit manufacturer’ instruction (Qiagen SpA, 
Milano, Italy) as previously described
13
; after re-suspension and lysis of the cells with insulin 
syringes to break the cell membrane and to allow acid guanidinium thiocyanate-phenol-chloroform 
to entry at intracellular level, samples were selective bound on a silica-based membrane and 
speeded on a microspin centrifuge. A specific high-salt buffer system allows RNA to bind to the 
RNeasy silica membrane and contaminants were washed out. High-quality RNA were then eluted in 
50 µl of RNAse free water. The total RNA concentration was determined in all samples by 
measuring the spectrophotometer absorbance at 260 and 280 nm (BioPhotometer Eppendorf, Milan, 
Italy) and calculated using the Beer-Lambert law, with expected values between 1.8-2.1. The RNA 
samples were stored at -80 °C for use in gene expression studies.  
First-strand cDNA was synthesized by IScript cDNA Synthesis Kit (Bio-Rad Laboratories Inc., 
Hercules, CA, USA), which uses the Moloney Murine Leukemia Virus (M-MuLV) reverse 
transcriptase, optimized for reliable cDNA synthesis over 1 µg of total RNA as template. Reverse 
transcriptase reaction sequence consisted of incubation at 25°C for 5 min, followed by three 
different cycles at 42°C for 30 min and 45–48 °C for 10 min, in order to better separate the strands. 
The reverse transcriptase enzyme was inactivated by heating to 85 °C for 5 min. The cDNA 
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samples obtained were placed on ice and stored at 4 °C. Natriuretic peptide (atrial natriuretic 
peptide, ANP, B-type and C-type natriuretic peptides, BNP and CNP, together with their specific 
receptor, NPR-A, NPR-B and the clearance one NPR-C), endothelin system (prepro-ET-1 and 
receptors ET-A and ET-B) and Connexin (CX)-43 expression was determined by Real-time PCR, 
Real-Time PCR performed in duplicate on the Bio-Rad C1000 TM thermal cycler (CFX-96 Real-
Time PCR detection systems, Bio-Rad) as previously described.
14
 For monitoring cDNA 
amplification, a third-generation fluorophore, EvaGreen, was used (SsoFAST EvaGreen Supermix, 
Bio-Rad). Real-Time PCR was performed in a volume of 20 µl per reaction, including 0.2 µM of 
each primer (Sigma-Aldrich, St. Louis, MO, USA), samples, reagent and sterile H2O. Since Real-
Time PCR efficiency is highly dependent on the primers used, their sequences were accurately 
selected and whenever possible, intron-spanning primers were selected to avoid amplification of 
genomic DNA. To better improve primers specificity, the regions of homology were checked and 
eluded as well as secondary structures leading to poor or no yield of the product was avoided. 
Amplification protocol started with 98 °C for 30 s followed by 40 cycles at 95 °C for 5 s and the 
optimal annealing temperature was assessed performing a gradient PCR; to verify amplification 
efficiency a standard curve obtained by scalar dilution of a cDNA pool (1:5, 1:25, 1:125, and 
1:625), was generated. Efficiency was evaluated of 90-105% with a linear standard curve R2 
coefficient ≥ 0.998. To assess product specificity, amplicons were systematically checked by 
melting curve analysis. Melting curves were generated from 65°C to 95 °C with increments of 0.5 
°C/cycle. 
Statistical methods 
In an effort to provide greater transparency of our results between research laboratories, this study 
was carried out to conform to the Minimum Information for publication of Quantitative Real-Time 
PCR Experiments (MIQE).
15
 Nine reference genes were tested and the GeNorm technology 
integrated in the Bio-Rad’s CFX96 manager software (CFX-96 Real-Time PCR detection systems, 
Bio-Rad Laboratories Inc., Hercules, CA, USA) was used to establish the most stably expressed 
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gene, as described by Vandesompele et al.
16
 Normalization of mRNA expression results was made by 
the geometric mean of the three most stably expressed genes. The relative quantification was 
performed by ∆∆Ct method. When expression values were not normally distributed, the logarithmic 
transformation of data was used for statistical analysis. Differences between more than two 
independent groups were analyzed by Fisher’s test after ANOVA. Differences between two 
independent groups were assessed by unpaired t-test. The results are expressed as mean ± SEM and 
p-value was considered significant when < 0.05. The association between different variables were 
assessed by linear regression. All data were analyzed by using Statview 5.0.1 software released for 
Windows Statistical (SAS Institute, Inc., Cary, NC, USA). 
RESULTS 
Mechanical tests 
All the samples presented wet aspect, flexible behaviour and adhesive properties to flat surfaces, 
regardless the SWCNTs concentration. Mechanical test results clearly indicated an increase of the 
biomaterial stiffness as the SWCNTs concentration increases, with a Pearson coefficient of 0.97 
(Fig. 1 a-c). As the elastic modulus, also the failure stress increases with the amount of CNTs: the 
failure stress spans from 139 ± 11 kPa of the pure gel to 428 ± 13 kPa of 1.3% SWCNTs with a 
good linear correlation (Pearson = 0.91). The increase in SWCNT concentration leads to a decrease 
in the failure strain: the pure gelatin-GP gel has a failure strain of 32.6 ± 2,9%, while it is reduced to 
almost one third (13.9 ± 3 %) with 1.3% w/w SWCNT concentration: in this case, the Pearson 
coefficient is -0.89. The elastic behaviour of the gelatin-SWCNT samples can be modelled using the 
Halpin–Tsai equations, which gave reasonable estimates for effective stiffness Ec (Table 1):  
(1) 
(2) 
Ec
Em
=
3
8
1+ 2 L /D( )ηLVf
1−ηLVf








+
5
8
1+ 2ηTVf
1−ηTVf








ηL =
Ep / Em( ) −1
Ep / Em( ) + 2 L /D( )
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(3) 
where Em is the pure gelatin elastic modulus, Ep is the SWCNT elastic modulus, estimated around 
500 GPa.
17
 The ratio between the length L and the diameter D of the SWCNT was set to 100.
17-21
  
The Vf (final volume) is expressed using the dry mass of both gelatin and SWCNTs.
 21
 
Electrical tests 
All the gelatin-SWCNT-GP samples show a capacitive behaviour, with a decrease of the modulus 
of the impedance as the frequency increases (Fig. 1 d,e) 
As the SWCNT concentration increase, the impedance decreases: this variation is more evident at 
low frequency. For instance, respect to the pure gelatin gel, at 1 kHz the impedance decreases of 
50% with just 0.3% SWCNT; at 1.3%, the variation amount is 85%. These decreases are linear 
correlated with the filler concentration, showing a Pearson coefficient of -0.85. 
Cytotoxicity and cell growth 
Results of cytotoxicity test for the different gelatin-SWCNT scaffolds, reported in Fig. 2a, show cell 
viability (98±3%) similar to negative control while cells treated with DMSO (positive control) 
presented a reduction of 80% in viability value. Scaffolds, presenting a viability value above 70%, 
can be defined non cytotoxic. Taking in account results of impedance tests, cell growth test was 
performed. Cell growth analysis for differentiated cells (Fig. 2b) showed a slowing down at day 7 
and a final value lower respect to control for both the differentiation protocols. Selected scaffolds’ 
samples were cultured for 10 days. The test showed an initial reduction of cell viability (day 3) 
followed by its recovery and a final value similar to control (Fig. 2c). The final rate of colonization 
resulted satisfying on two gelatin-SWCNT scaffold typologies: SWCNT0.3% and SWCNT0.9%. 
Immunohistochemistry 
Differentiated cells and scaffold were analyzed with immunohistochemical analysis to evaluate 
morphological changes through expression of myogenic- and cardiac-specific markers: Myogenin 
ηT =
Ep / Em( ) −1
Ep / Em( ) + 2
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and MYL-2, respectively. The reduction of FBS concentration in C1% samples produced the 
myogenic differentiation process, highlighted by elongated cell shape (Fig. 3a) and their fusion to 
form a myotubule and increased concentration of fluorescence signal in these cells, linked to 
augmented expression of Myogenin. RA-treated cells exhibited rather different morphological 
changes, typical of cardiac differentiation, with large and rounded multinucleated cells evidenced a 
fluorescence signal increase of MYL-2 in treated cells (Fig. 3b). Unfortunately, the strong 
background of scaffolds, generated by genipin used as cross-linker for their preparation, did not let 
to observe significant indications on scaffold-induced differentiation. 
Real-Time PCR analysis  
Condition Assessment and selection of reference gene set 
After the optimization of the thermal-cycle profile of each designed PCR primer and adequate 
quantification of Real-time PCR efficiency, that resulted in the range of 95-105% with a linear 
standard curve greater than |0.990| as reported in Table 2, the selected genes were run in each 
system analyzed: 1) C10%+C1%+CRA; 2) C10%+SWCNT0.3%+SWCNT0.9%, The threshold cycle range 
resulted different among genes tested in a cell-specific manner. An example for the first system was 
reported in Fig. 4a. This analysis provided the gene expression stability measure (M) for each 
reference gene, which allowed ranking them from the least stable (higher M value) to the most 
stably expressed (lowest M value). Thus, ordering genes according to M values (M<1 for 
heterogeneous groups) in the analyzed conditions, the rank was different depending on the cell 
system considered. In particular, the more stable genes for the first system C10%+C1%+CRA were 
YWHAG, UBC and PPIA (M= 0.9) (Fig. 4b) while for the second one we chose only two reference 
genes, UBC and PPIA (M= 0.685). In fact, although we analysed nine reference genes for the M 
value evaluation the stability was reached only with two genes (M=0.685) because the addition 
third gene created a destabilization of our system reaching high expression stability with M-value > 
of default limit (M=1.5). A similar behaviour was observed in previous study of our
22, 23
 but unlike 
of this situation when the system was analysed with a specific software as NormFinder the three 
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reference gene selected resulted not co–regulated despite the higher M value while in the system 
C10%+SWCNT0.3%+SWCNT0.9%, also analyzing them with NormFinder the optimal setting resulted 
composed by two housekeeping. 
Natriuretic and endothelin system mRNA expression levels in H9c2 cell line treated with FBS 1% 
and retinoic acid  
In order to evaluate cardiac phenotype, the NP and ET system were studied. As reported in Figure 
5, a significantly increase of ANP, BNP and CNP was observed in CRA with respect to C10% and 
C1% as well as of their guanylate-cyclase receptors, NPR-A and NPR-B unlike the clearance 
receptor NPR-C resulted significantly decreased in CRA. Furthermore, CRA revealed an increased 
expression of both ET-A and ET-B receptors in parallel with a decreased ET-1 levels with respect 
to C10% and C1% (Fig. 6). CX-43, evaluated as a marker of cardiocytes proliferation and 
differentiation, resulted higher in CRA (1.096±0.49) with respect to both C10% (0.785±0.12) and C1% 
(0.567±0.25) even though not significantly.  
Natriuretic and endothelin system mRNA expression levels in gelatin-based scaffold at 0.3% e 
0.9% of SWCNT 
In order to evaluate H9c2 cell line growth and differentiation on SWCNT scaffolds, NP and ET 
systems mRNA expression were measured. NPs resulted decreased in SWCNT0.3% and SWCNT0.9% 
with respect to C10% after 7 days of culture, mainly due to a lacking of complete differentiation in 
cardiac phenotype during these few days (Fig. 7 a-c). In parallel, a “down-regulation” of all receptor 
subtypes was observed in SWCNT0.3% and SWCNT0.9% with respect to the control group (C10%) 
(Fig. 7 d, e).  
As for NPs, mRNA expression levels of ET-1, ET-A and ET-B were lower in SWCNT0.3% and 
SWCNT0.9% with respect to C10%, while any statistical difference was observed between gelatin-
based scaffold at 0.3/0.9 concentration of SWCNTs (Fig. 8). 
CX-43, evaluated as a marker of myocytes differentiation during culture on CNT scaffold, was 
significantly decreased in SWCNT0.3% and SWCNT0.9% (0.15±0.06 and 0.18±0.07, respectively) 
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with respect to C10% (0.76±0.1; p= 0.002 C10% vs SWCNT0.3% and p= 0.007 C10% vs SWCNT0.9%), 
confirming a low growth/differentiation induced by CNT on this support.  
 
DISCUSSION 
The present study was finalized to evaluate new gelatin-based CNT supports useful for cardiac 
tissue engineering applications aiming at providing living, force-producing heart muscle tissue that 
might be transplanted on injured hearts. To date, the search for nanostructurable materials able to 
provide active support and interactions with biosystems at molecular and submolecular level is very 
active. In recent years, CNTs are certainly numbered among the most interesting and studied 
nanomaterials for a variety of applications.
11,12
 Here, we have developed scaffolds composed by 
gelatin (5%) mixed with single-well carbon nanotubes (SWCNTs, 0.3% and 0.9%), where a pool of 
H9c2 cell line was seeded. The H9c2 cell line is currently used as a gold standard in-vitro model 
since, due to its biochemical, morphological and electrical/hormonal signalling properties, it is able 
to mimic the behaviour of skeletal and cardiac muscle.
24
 A preliminary goal of the study was to 
evaluate any phenotypical changes of H9c2 cell line, due to two different culture conditions: FBS 
reduction (from 10% to 1%) and all-trans retinoic acid culture enrichment.
24,25
 In fact, one 
important feature of this cell line is its ability to differentiate from mono-nucleated myoblasts to 
myotubes when cultured in a low serum concentration media, getting an elongated shape and 
positioning in a parallel fashion.
26
 As expected, during the differentiation process in FBS reduction, 
H9c2 presented a skeletal muscle phenotype, as was evidenced by presence of Myogenin, a cell 
type-specific differentiation marker, while the addiction of RA to a 1% serum media induced a 
cardiac muscle phenotype, characterized by the overexpression of MYL-2. The differentiation of 
H9c2 cell, obtained with serum decrease and RA addition, led to a transcriptional up-regulation of 
genes involved in cardiac differentiation as NPs used as a marker for ventricular cardiomyocyte 
maturation.
27-30
 Moreover, a shift in the maturational phenotype of cultured cardiac cells is 
supported by measurement of steady state mRNA levels of the ET system that can be modulated 
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during the differentiation into the cardiac phenotype exhibiting enhancing expression of both 
receptors in parallel to a decrease of ET-1 itself. Furthermore, CX-43 was also evaluated to confirm 
the results, since it is the only connexin known to be expressed in the working myocardium. The 
gap junction channels formed by CX-43 most likely have important roles during heart 
development.
31 
In our samples, CX-43 levels resulted higher in cell treated with retinoic acid with 
respect to both C10% and C1%. These data provided the basis for the choice of FBS 10% as an 
optimal culture medium supplement for H9c2 cells on SWCNTs, instead of supplement with RA or 
depletion of FBS, in order to avoid confounding effect due to rapid cardiac differentiation or a more 
myogenic-like phenotype. In the second phases of our study, in order to increase the effect of the 
scaffold composites on cell phenotype changes, SWCNTs were incorporated into a natural polymer 
(gelatin), in presence of genipin, used as a cross-linker, which further increases proliferation, 
differentiation and electrical conductivity of cell seeded onto. The electric characterization showed 
that scaffolds with SWCNT concentration at 0.3% and 0.9% might be valid support providing an 
anchorage for cells on the scaffold surface, and stability for proliferation supporting the process of 
differentiation, elongation and electric conductivity. Despite of these good properties, the analysis 
of H9c2 cell growth curves showed a decrease in cell viability in the first 7 days of culture, 
probably due to the time required by those cells of adapting to the new material. Moreover, any 
changes were also observed in the mRNA expression of both NP and ET-1 systems neither in 
SWCNT0.3% nor SWCNT0.9% with respect to controls (C10%). 
A possible explanation could be a limited time of H9c2 culture, not able to stimulate changes in the 
expression pattern of specific cardiac genes involved in the maturation process of a cardiomyocyte-
like phenotype. Furthermore, the transcription level of CX-43 resulted unchanged in SWCNTs at 
0.3% and 0.9%, underlining a lack of cell proliferation and migration ability. 
Thus, the reduction of both proliferation rate and expression of the specific markers agree with 
previous reports investigating cardiomyocyte-like differentiation
24,30-32
 and were mainly accounted 
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for a shift in cardiomyocyte maturational status that has not been yet occurred since H9c2 required 
additional time to adapt to the scaffold. 
Although further studies are needed, our data shown that SWCNTs conductive properties can 
potentially enhance cellular electrical excitability, leading to more mature cardiac phenotype in 
H9c2. On the other hand, the peculiar combination of mechanical strength with low electrical 
resistance and high thermal conductivity properties, makes SWCNTs good candidates for a wide 
variety of biomedical applications, in particular in cardiac tissue engineering. 
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Figure Legend 
Figure 1: Mechanical and electrical tests of gelatin-SWCNT-genepin samples. a) elastic modulus; 
b), failure stress; c) failure strain; d) Modulus and e) phase at different SWCNT concentration. 
Figure 2: Assessment of cytotoxicity and cellular vitality. a) H9c2 cell line viability testing 
different gelatin-SWCNT-genepin concentrations (0.3%; 0.5%; 0.7%; 0.9%, 1.3%) with respect to 
Positive control (cells treated with DMSO 5%) and negative control (C10%); b) cell growth curves of 
system 1 (C10%+C1%+CRA) at different days of culture; c) cell growth curves of system 2 
(C10%+SWCNT0.3%+SWCNT0.9%) at different days of culture  
Figure 3: H9c2 cells differentiation characterization. Representative images of the effect of serum 
(FBS) depletion and retinoic acid (RA) supplementation on H9c2 cell morphology. a) typical 
morphology of undifferentiated mononucleated and small spindle shaped myoblasts due to a 
FBS1% evidenced by Myogenin; b) multinucleated and rounded cardiomyocytes due to 
concomitant addition of 50 nM RA evidenced by MYL-2 
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Figure 4: Selection of the optimal set of reference genes. a) Ct values range in C10%+C1%+CRA. 
Each box consists of five horizontal lines displaying the 10th, 25th, 50th (median), 75th, and 90th 
percentiles of the variable. All values above the 90th percentile and below the 10th percentile are 
plotted separately. b) evaluation of reference gene expression stability (M-value) during stepwise 
exclusion of the least stable gene using GeNorm software. 
Figure 5: Molecular characterization of H9c2 cell line before and after the differentiation process 
by expression analysis of the natriuretic peptide system. Relative expression of a) ANP; b) BNP; c) 
CNP; d) NPR-A; e) NPR-B; f) NPR-C in C10%+C1%+CRA. 
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive control 1, 
cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light grey); CRA: positive 
control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)] 
Figure 6: Molecular characterization of H9c2 cell line before and after the differentiation process 
by expression analysis of the endothelin system. Relative expression of a) Pre-proET-1; b) ET-A; c) 
ET-B in C10%+C1%+CRA. 
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive control 1, 
cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light grey); CRA: positive 
control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)] 
Figure 7: Molecular characterization of gelatin-single walled nanotubes (SWCNT)-genepin 
scaffolds by expression analysis of the natriuretic peptide system. Relative expression of a) ANP; 
b) BNP; c) CNP; d) NPR-A; e) NPR-B; f) NPR-C in C10%+SWCNT0.3%+ SWCNT0.9%. 
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C0.3%: positive control 1, 
cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light grey); CRA: positive 
control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)] 
Figure 8: Molecular characterization of gelatin-single walled nanotubes (SWCNT)-genepin 
scaffolds by expression analysis of the endothelin system. Relative expression of a) Pre-proET-1; b) 
ET-A; c) ET-B in C10%+SWCNT0.3%+ SWCNT0.9%.  
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[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive control 1, cells 
supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light grey); CRA: positive control 2, 
cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)] 
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Table 1: samples elastic modulus (Ec) expresses as percentage of the pure gelatin-
genepin matrix (Em). The model error is calculated as “Experiment” minus “Model”. 
 
SWCNT 
Concentration (%) 
Ec/Em (%)  
Model error 
(%) Experiment Model 
0.3 118 123 5 
0.5 140 139 1 
0.7 160 154 6 
0.9 177 170 7 
1.3 189 200 10 
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Table 2: Primer sequence details of the analyzed gene 
 
 
GENE PRIMER SEQUENCE 
GENBANK, 
ACCESSION # 
LOCATION 
AMPLICON  
LENGHT, bp 
TEMPERATURE, 
 °C 
EFFICIENCY, 
% 
R2 
ACTB 
F: GTCGTACCACTGGCATTGTG 
R:CTCTCAGCTGTGGTGGTGAA 
NM_031144 chr 12p11 181  60 104.3%  0.998  
GAPDH 
F: CTACCCACGGCAAGTTCAAC 
R: CCAGTAGACTCCACGACATAC 
NM_017008 chr 4q42 98  60 98.4%  0.999  
GUSB 
F: ATCCCGGCCAGCATGTCCCCAAG 
R: GTTCCCGCGAAGGGGTCTCCT 
NM_017015 chr 12q12 124  60 100.2%  0.999  
PPIA 
F: CCAAACACAAATGGTT 
R: ATTCCTGGACCCAAAACGCT 
NM_017101 chr 14q21 100 60 98.4% 0.998 
RPL-13A 
F: GGATCCCTCCACCCTATGACA 
R: CTGGTACTTCCACCCGACCTC 
NM_173340.2 chr 1q22 130 60 101%  0.999  
SDHA 
F: CTCTTTTGGACCTTGTCGTCTTT 
R: TCTCCAGCATTTGCCTTAATCGG 
NM_130428 chr 1p11 102 60 104.7 0.999 
TBP 
F: CACCGTGAATCTTGGCTGTAAAC 
R: CGCAGTTGTTCGTGGCTCTC 
NM_001004198 chr 1q12 123 60 105 0.998 
UBC 
F: ATCTAGAAAGAGCCCTTCTTGTGC 
R: ACACCTCCCCATCAAACCC 
NM_017314.1 chr 12q15 50  60 95%  0.997  
YWHAG 
F: TTCCTAAAGCCCTTCAAGGCA 
R: GGCTTTCTGCACTAGTTGCTCG 
NM_019376.2 chr 12q12 100 60 95.3%  0.997  
ANP 
F: AAGTGTAGATGAGTGGTT 
R: TGGTGCTGAAGTTTATTC 
NM_012612 chr 5q36 118 58 95.3 0.999 
BNP 
F: ATCTGTCGCCGCTGGGAGGT 
R: TGGATCCGGAAGGCGCTGTCT 
NM_173340 chr 1q22 130 60 101 0.999 
CNP 
F: GGAGCCAATCTCAAGGGA 
R: TGCCGCCTTTGTATTTGC 
NM_053750 chr 9q35 70 60 105 0.998 
NPR-A 
F: AGAGCCTGATAATCCTGAGTA 
R: A TCCACGGTGAAGTTGAAC 
NM_012613 chr 2q34  81 58 95.4 0.998 
NPR-B 
F: CCCATCCTGTGATAAAACTCC 
R: AAGCTGGAAACACCAAACA 
NM_053838 chr 2q16 89 60 104 0.999 
NPR-C 
F: GGACCGCGAAGCCTGAGTTTGAGA 
R: ATGGACACCTGCCCGGCGATACCT 
NM_012868 chr 9q35 240 64 100.3 0.998 
Pre-proET-1 
F: GTCTAAGCGATCCTTGAA  
R: AATTCCAGCACTTCTTGT 
NM_012548 chr 17p12 98 58 96 0.997 
ET-A 
F: CTCCACAGTAGTAGCACAT 
R: TAGCCAGTCCTCACAGTA 
NM_012550 chr 19q11 75 60 95 0.997 
ET-B 
F: GATACGACAACTTCCGCTCCA 
R: GTCCACGATGAGGACAATGAG 
NM_017333 chr 15q21-q22 85 64 101 0.990 
CX-43 
F: CTCAACAACCTGGCTGCGAAA 
R: GGTGGGCACAGACACGAATAT 
NM_012567.2 chr 20q11 60 60 103.2 0.998 
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Table legend. ACTB: beta-actin; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GUSB: glucuronidase, beta; PPIA: peptidylprolyl isomerase a (cyclophilin a); RPL13: 
ribosomal protein l13a; SDHA: succinate dehydrogenase complex, subunit a, flavoprotein; TBP: tata binding protein; UBC: ubiquitin C; YWHAG: tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide; ANP: atrial natriuretic peptide; BNP: B-type (or brain) natriuretic peptide; CNP: C-type 
natriuretic peptide; NPR-A: Natriuretic peptide receptor A; NPR-B: Natriuretic peptide receptor B; NPR-C: Natriuretic peptide receptor C or clearance receptor; Pre-proET-1: 
endothelin 1 gene; ET-A: endothelin receptor A; ET-B: endothelin receptor B; CX-43: connexin-43  
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Figure 1: Mechanical and electrical tests of gelatin-SWCNT-genepin samples. a) elastic modulus; b), failure 
stress; c) failure strain; d) Modulus and e) phase at different SWCNT concentration.  
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Figure 2: Assessment of cytotoxicity and cellular vitality. a) H9c2 cell line viability testing different gelatin-
SWCNT-genepin concentrations (0.3%; 0.5%; 0.7%; 0.9%, 1.3%) with respect to Positive control (cells 
treated with DMSO 5%) and negative control (C10%); b) cell growth curves of system 1 
(C10%+C1%+CRA) at different days of culture; c) cell growth curves of system 2 
(C10%+SWCNT0.3%+SWCNT0.9%) at different days of culture  
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Figure 3: H9c2 cells differentiation characterization. Representative images of the effect of serum (FBS) 
depletion and retinoic acid (RA) supplementation on H9c2 cell morphology. a) typical morphology of 
undifferentiated mononucleated and small spindle shaped myoblasts due to a FBS1% evidenced by 
Myogenin; b) multinucleated and rounded cardiomyocytes due to concomitant addition of 50 nM RA 
evidenced by MYL-2  
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Figure 4: Selection of the optimal set of reference genes. a) Ct values range in C10%+C1%+CRA. Each box 
consists of five horizontal lines displaying the 10th, 25th, 50th (median), 75th, and 90th percentiles of the 
variable. All values above the 90th percentile and below the 10th percentile are plotted separately. b) 
evaluation of reference gene expression stability (M-value) during stepwise exclusion of the least stable 
gene using GeNorm software  
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Figure 5: Molecular characterization of H9c2 cell line before and after the differentiation process by 
expression analysis of the natriuretic peptide system. Relative expression of a) ANP; b) BNP; c) CNP; d) 
NPR-A; e) NPR-B; f) NPR-C in C10%+C1%+CRA.  
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive 
control 1, cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light 
grey); CRA: positive control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)]  
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Figure 6: Molecular characterization of H9c2 cell line before and after the differentiation process by 
expression analysis of the endothelin system. Relative expression of a) Pre-proET-1; b) ET-A; c) ET-B in 
C10%+C1%+CRA.  
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive 
control 1, cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light 
grey); CRA: positive control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)]  
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Figure 7: Molecular characterization of gelatin-single walled nanotubes (SWCNT)-genepin scaffolds by 
expression analysis of the natriuretic peptide system. Relative expression of a) ANP; b) BNP; c) CNP; d) 
NPR-A; e) NPR-B; f) NPR-C in C10%+SWCNT0.3%+ SWCNT0.9%.  
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C0.3%: positive 
control 1, cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light 
grey); CRA: positive control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)]  
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Figure 8: Molecular characterization of gelatin-single walled nanotubes (SWCNT)-genepin scaffolds by 
expression analysis of the endothelin system. Relative expression of a) Pre-proET-1; b) ET-A; c) ET-B in 
C10%+SWCNT0.3%+ SWCNT0.9%.  
[GRAPH LEGEND: C10%: negative control, cells supplemented with 10% FBS (white bar); C1%: positive 
control 1, cells supplemented with 1% FBS, useful to evaluate potential myogenic differentiation (light 
grey); CRA: positive control 2, cells supplemented with 1% FBS and 50 nM retinoic acid (black bar)]  
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